Researchers from The Hospital for Sick Children (SickKids) recently decoded how human antibodies protect us from the malaria parasite, which kills more than 600,000 people worldwide annually. The CMCF facility at the Canadian ...
Nov 27, 2023
0
41
Another at-home treatment option for the flu and other respiratory illnesses is closer to becoming a reality, thanks to new research that found inhaled, monoclonal antibodies against SARS-CoV-2 significantly reduced COVID-19 ...
Nov 7, 2023
0
34
The Wistar Institute's David B. Weiner and collaborators have engineered novel monoclonal antibodies that engage natural killer (NK) cells through a unique surface receptor that activates the immune system to fight against ...
Nov 1, 2023
0
21
A combined team of medical researchers from Columbia University and the University of Michigan has found that, despite multiple mutations, the SARS-CoV-2 omicron subvariant BA.2.86 does not appear to be more dangerous than ...
Repeated outbreaks of bat-derived coronaviruses among humans and other mammals have heightened the need for a broad range of therapeutics—monoclonal antibodies and antivirals—treatments that can come immediately "off-the-shelf" ...
For patients with polymyalgia rheumatica with relapse during tapering of glucocorticoid therapy, treatment with sarilumab, the human monoclonal antibody that binds to the interleukin-6 receptor α, is efficacious for achieving ...
Oct 5, 2023
0
1
An antibody in single-chain fragment variable (scFv) format that binds to the powerful opioid carfentanil was shown to reverse signs of carfentanil overdose in preclinical tests conducted by scientists at Scripps Research.
Aug 7, 2023
0
40
Vanderbilt University Medical Center and Stanford University researchers discovered a potent, cross-neutralizing human monoclonal antibody against the respiratory syncytial virus (RSV) and human metapneumovirus (hMPV).
Aug 7, 2023
0
47
Exceptionally potent antibodies that can neutralize virtually all known variants of the COVID-19 virus—including omicron, as well as other dangerous animal coronaviruses that could potentially cause future outbreaks—have ...
Jul 28, 2023
0
338
A new technology developed at Caltech is designed to make more potent vaccines, beginning with SARS-CoV-2 (the virus that causes COVID-19). In mouse studies, the prototype vaccine elicited five times more antibodies than ...
Jul 25, 2023
0
42
